GEMINI-1 (EFC16033) A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis

  • Brock, Constanze (Researcher)
  • Cerinza-Sick, Cristina (Researcher)
  • Eger, Stephan (Researcher)
  • Gschwandtner, Anna (Researcher)
  • Kellermair, Lukas (Researcher)
  • Lorenz, Maria (Researcher)
  • Schürz, Natascha (Researcher)
  • Sukalo, Natasa (Researcher)
  • Traxler, Gerhard (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

StatusFinished
Effective start/end date01.10.2021 → 31.12.2024

Fields of science

  • 302052 Neurology